Patent · US Active

Fusion proteins comprising a Mtu ΔI-CM intein variant and methods of protein purification

US11136360B2 · kind B2 · utility

0Cited by
2References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 19, 2019
Grant dateOct 5, 2021
Priority date
Expiry dateDec 19, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure describes a Mtu ΔI-CM intein variant containing one or more mutations or a biologically active fragment thereof, and a method for producing and purifying a molecule of interest using the intein variant. Further described are isolated fusion proteins comprising the intein variant and a tag and a molecule of interest. Also described are expression systems for expressing the intein variant as well as polypeptide screening methods employing the intein variant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.